Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* LAMPROPOULOS FRED P	2. Issuer Name and Ticker or Trading Symbol MERIT MEDICAL SYSTEMS INC [ MMSI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) PRESIDENT AND CEO
(Last) (First) (Middle) 1600 WEST MERIT PARKWAY	3. Date of Earliest Transaction (MM/DD/YYYY) 2/26/2021
(Street) SOUTH JORDAN, UT 84095 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, No Par Value	2/26/2021		A		8840 ⁽¹⁾	A	$0	976756	D
Common Stock, No Par Value	2/26/2021		F		3893	D	$55.72	972863	D
Common Stock, No Par Value								95862.542	I	By 401(k) Plan ⁽²⁾
Common Stock, No Par Value								90	I	By spouse as custodian for child
Common Stock, No Par Value								1269	I	By spouse

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-qualified stock options (right to buy)	$17.27							2/13/2016 ⁽³⁾	2/13/2022	Common Stock	5000		5000	I	See footnote ⁽⁴⁾
Non-qualified stock options (right to buy)	$16.05							1/28/2017 ⁽⁵⁾	1/28/2023	Common Stock	50000		50000	D
Non-qualified stock options (right to buy)	$16.05							1/28/2017 ⁽⁶⁾	1/28/2023	Common Stock	6000		6000	I	See footnote ⁽⁴⁾
Non-qualified stock options (right to buy)	$28.20							4/14/2018 ⁽⁷⁾	4/14/2024	Common Stock	200000		200000	D
Non-qualified stock options (right to buy)	$28.20							4/14/2018 ⁽⁸⁾	4/14/2024	Common Stock	6000		6000	I	See footnote ⁽⁴⁾
Non-qualified stock options (right to buy)	$44.80							3/2/2019 ⁽⁹⁾	3/2/2025	Common Stock	38002		38002	D
Non-qualified stock options (right to buy)	$44.80							3/2/2019 ⁽¹⁰⁾	3/2/2025	Common Stock	4000		4000	I	See footnote ⁽⁴⁾
Non-qualified stock options (right to buy)	$55.73							3/1/2020 ⁽¹¹⁾	3/1/2026	Common Stock	159151		159151	D
Non-qualified stock options (right to buy)	$55.73							3/1/2020 ⁽¹²⁾	3/1/2026	Common Stock	2000		2000	I	See footnote ⁽⁴⁾
Non-qualified stock options (right to buy)	$37.71							2/26/2021 ⁽¹³⁾	2/26/2027	Common Stock	100334		100334	D

Explanation of Responses:
(1)	These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020.
(2)	Represents plan holdings as of 2/26/2021.
(3)	Became exercisable in equal annual installments of 20% commencing 2/13/2016.
(4)	Represents derivative securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse.
(5)	Becomes exercisable in equal annual installments of 20% commencing 1/28/2017.
(6)	Original grant of 7,500 options was to become vested and exercisable in equal annual installments of 20% commencing 1/28/2017. Options not vested as of 6/22/2020 have been forfeited.
(7)	Becomes exercisable in equal annual installments of 20% commencing 4/14/2018.
(8)	Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 4/14/2018. Options not vested as of 6/22/2020 have been forfeited.
(9)	Becomes exercisable in equal annual installments of 20% commencing 3/2/2019.
(10)	Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/2/2019. Options not vested as of 6/22/2020 have been forfeited.
(11)	Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
(12)	Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
(13)	Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
LAMPROPOULOS FRED P 1600 WEST MERIT PARKWAY SOUTH JORDAN, UT 84095	X		PRESIDENT AND CEO